Assessment of costs and benefits of drug therapy for treatment-resistant schizophrenia in the United Kingdom.

Davies, L M

Assessment of costs and benefits of drug therapy for treatment-resistant schizophrenia in the United Kingdom. [electronic resource] - The British journal of psychiatry : the journal of mental science Jan 1993 - 38-42 p. digital

Publication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't

0007-1250

10.1192/bjp.162.1.38 doi


Adult
Clozapine--economics
Cost-Benefit Analysis
Humans
Retrospective Studies
Schizophrenia--drug therapy
United Kingdom